Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Steven Cohen’s New High Dividend Stock Picks

Page 1 of 2

The 10-year U.S treasury bond yield went below the critical 2% mark recently, hitting a fresh 5-month low at 1.99%. With lukewarm consumer spending and low inflation, market participants feel that the Fed will remain ‘patient’ for at least a few more months and hence are making a beeline for bonds. Although this day-to-day variation in yield doesn’t impact those fixed-income investors who are already invested in bonds, for new investors, the less than 2% yield definitely reduces the appeal of them, regardless of the safety they provide. Which is why we feel that at times such as now, fixed-income investors looking to make fresh investments should consider dividend-paying stocks as an alternative to bonds. While these stocks carry significantly more risk than bonds, from a risk-reward perspective, when yields of bonds fall below a critical mark, the rewards of investing in dividend stocks far outweigh the associated risks.

We at Insider Monkey continuously track the portfolios of renowned hedge funds to find hidden small-cap gems and in our pursuit to do so, we also come across stocks with decent dividend yields that are popular among hedge funds. In this article we are going to take a closer look at three dividend-paying companies in which the family office of billionaire trader Steve Cohen, Point 72 Asset Management, has acquired a large stake. Since Mr. Cohen is famous on the Street for his brilliant track record of consistently outperforming the market, it is quite possible that he has made these investments with a focus on capital appreciation rather than to generate income. However, that adds to the advantage of investing in them because not only do these stocks have a decent dividend yield – much better than bonds – but they also have the potential to appreciate in the future and add to the gains of their investors.


We pay attention to hedge funds’ moves because our research has shown that hedge funds like Point72 are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 102% since then and outperformed the S&P 500 Index by more than 53 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

Steve Cohen
Steve Cohen
Point72 Asset Management

Let’s start with National-Oilwell Varco, Inc. (NYSE:NOV). During the second quarter, Point 72 Asset Management acquired 385,000 shares of the company in addition to call options underlying a further 415,000 shares. The stakes are worth $18.59 million and slightly above $20 million respectively as of June 30. Like most oil and natural gas stocks, the decline in oil prices has weighed heavily on the stock of National-Oilwell Varco, Inc. (NYSE:NOV) and the continuous decline it has had since the start of the year has eroded 41.6% of its market cap year-to-date. However, this decline has also resulted in its quarterly dividend of $0.46 per share now representing a lucrative dividend yield of 4.76%. In the last couple of days several analysts and brokerages have lowered their outlook on the stock. On October 14, analysts at Robert W. Baird reduced their price target on the stock to $42 from $48, while keeping their rating unchanged at ‘Neutral’. This was followed by analysts at Societe Generale reiterating their ‘Neutral’ rating on the stock while reducing their price target on it to $40 from $47. Bruce Berkowitz‘s Fairholme (Fairx) was another fund that initiated a stake in National-Oilwell Varco, Inc. (NYSE:NOV) during the second quarter; it held over 1.13 million shares of the company as of June 30.

Follow National Oilwell Varco Inc (NYSE:NOV)
Trade (NYSE:NOV) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!